Unraveling the genomic complexity of small cell lung cancer.
作者信息
Karachaliou Niki, Sosa Aaron E, Rosell Rafael
机构信息
University Hospital Sagrat Cor, Oncology Institute Rosell, Barcelona, Spain;; Autonomous University of Barcelona, Germans Trias i Pujol Health Sciences Research Institute, Badalona, Spain;
University Hospital Sagrat Cor, Oncology Institute Rosell, Barcelona, Spain ;
出版信息
Transl Lung Cancer Res. 2016 Aug;5(4):363-6. doi: 10.21037/tlcr.2016.07.02.
Abstract
摘要
相似文献
1
Unraveling the genomic complexity of small cell lung cancer.
Transl Lung Cancer Res. 2016 Aug;5(4):363-6. doi: 10.21037/tlcr.2016.07.02.
2
Targeted drugs in small-cell lung cancer.
Transl Lung Cancer Res. 2016 Feb;5(1):51-70. doi: 10.3978/j.issn.2218-6751.2016.01.12.
3
Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036).
Cancer. 2019 Oct 15;125(20):3535-3544. doi: 10.1002/cncr.32372. Epub 2019 Jul 9.
4
Unraveling biophysical interactions of radiation pneumonitis in non-small-cell lung cancer via Bayesian network analysis.
Radiother Oncol. 2017 Apr;123(1):85-92. doi: 10.1016/j.radonc.2017.02.004. Epub 2017 Feb 22.
5
Unraveling chaotic attractors by complex networks and measurements of stock market complexity.
Chaos. 2014 Mar;24(1):013134. doi: 10.1063/1.4868258.
6
Genomic profiling of small-cell lung cancer: the era of targeted therapies.
Jpn J Clin Oncol. 2015 Jun;45(6):513-9. doi: 10.1093/jjco/hyv017. Epub 2015 Feb 10.
7
Chromosomal imbalances in human lung cancer.
Oncogene. 2002 Oct 7;21(45):6877-83. doi: 10.1038/sj.onc.1205836.
8
Genes and pathology of non-small cell lung carcinoma.
Semin Oncol. 2014 Feb;41(1):28-39. doi: 10.1053/j.seminoncol.2013.12.008. Epub 2013 Dec 12.
9
Detection of genomic instability in lung cancer tissues by random amplified polymorphic DNA analysis.
Carcinogenesis. 1998 Jan;19(1):233-5. doi: 10.1093/carcin/19.1.233.
10
Regulation of DNA polymerase POLD4 influences genomic instability in lung cancer.
Cancer Res. 2010 Nov 1;70(21):8407-16. doi: 10.1158/0008-5472.CAN-10-0784. Epub 2010 Sep 22.
引用本文的文献
1
Exploring lung cancer microenvironment: pathways and nanoparticle-based therapies.
Discov Oncol. 2025 Feb 11;16(1):159. doi: 10.1007/s12672-025-01902-y.
2
Small cell lung cancer with liver metastases: from underlying mechanisms to treatment strategies.
Cancer Metastasis Rev. 2024 Nov 25;44(1):5. doi: 10.1007/s10555-024-10220-8.
3
Targeting DNA Damage Response Deficiency in Thoracic Cancers.
Drugs. 2024 Sep;84(9):1025-1033. doi: 10.1007/s40265-024-02066-9. Epub 2024 Jul 13.
4
Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer.
Curr Oncol. 2023 Jun 30;30(7):6289-6315. doi: 10.3390/curroncol30070465.
5
A 2022 Update on Extensive Stage Small-Cell Lung Cancer (SCLC).
J Cancer. 2022 Jul 18;13(9):2945-2953. doi: 10.7150/jca.75622. eCollection 2022.
6
Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small-cell lung cancer: an international multicenter study.
J Pathol. 2022 Aug;257(5):674-686. doi: 10.1002/path.5922. Epub 2022 May 25.
7
Genomic and immunological profiles of small-cell lung cancer between East Asians and Caucasian.
Cancer Cell Int. 2022 Apr 29;22(1):173. doi: 10.1186/s12935-022-02588-w.
8
Small Cell Lung Cancer: State of the Art of the Molecular and Genetic Landscape and Novel Perspective.
Cancers (Basel). 2021 Apr 6;13(7):1723. doi: 10.3390/cancers13071723.
9
Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer.
J Oncol. 2020 Nov 19;2020:8811487. doi: 10.1155/2020/8811487. eCollection 2020.
10
Dysregulated Pyrimidine Biosynthesis Contributes to 5-FU Resistance in SCLC Patient-Derived Organoids but Response to a Novel Polymeric Fluoropyrimidine, CF10.
Cancers (Basel). 2020 Mar 26;12(4):788. doi: 10.3390/cancers12040788.
本文引用的文献
1
Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer.
PLoS One. 2016 Apr 7;11(4):e0152584. doi: 10.1371/journal.pone.0152584. eCollection 2016.
2
Cellular and molecular biology of small cell lung cancer: an overview.
Transl Lung Cancer Res. 2016 Feb;5(1):2-15. doi: 10.3978/j.issn.2218-6751.2016.01.02.
3
Immunotherapy for small-cell lung cancer: emerging evidence.
Future Oncol. 2016 Apr;12(7):931-43. doi: 10.2217/fon-2015-0012. Epub 2016 Feb 17.
4
Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?
J Thorac Oncol. 2016 Apr;11(4):453-74. doi: 10.1016/j.jtho.2016.01.012. Epub 2016 Jan 30.
5
Clinical correlation of extensive-stage small-cell lung cancer genomics.
Ann Oncol. 2016 Apr;27(4):642-7. doi: 10.1093/annonc/mdw005. Epub 2016 Jan 22.
6
A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo.
Sci Transl Med. 2015 Aug 26;7(302):302ra136. doi: 10.1126/scitranslmed.aac9459.
7
Comprehensive genomic profiles of small cell lung cancer.
Nature. 2015 Aug 6;524(7563):47-53. doi: 10.1038/nature14664. Epub 2015 Jul 13.
8
RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy.
Oncotarget. 2015 Jul 20;6(20):17873-90. doi: 10.18632/oncotarget.4286.
9
ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.
Cancer Discov. 2015 Jul;5(7):752-67. doi: 10.1158/2159-8290.CD-14-0849. Epub 2015 Jun 11.
10
RET mutation and expression in small-cell lung cancer.
J Thorac Oncol. 2014 Sep;9(9):1316-23. doi: 10.1097/JTO.0000000000000234.
Zotero 插件